School of Medicine
Showing 1-32 of 32 Results
-
Sanjiv Narayan
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Narayan directs the Computational Arrhythmia Research Laboratory, whose goal is to define the mechanisms underlying complex human heart rhythm disorders, to develop bioengineering-focused solutions to improve therapy that will be tested in clinical trials. The laboratory has been funded continuously since 2001 by the National Institutes of Health, AHA and ACC, and interlinks a disease-focused group of clinicians, computational physicists, bioengineers and trialists.
-
Ashwin K Nayak
Clinical Assistant Professor, Medicine
Current Research and Scholarly InterestsConversational AI, Large Language Models, Digital Therapeutics
-
Joel Neal, MD, PhD
Professor of Medicine (Oncology)
Current Research and Scholarly InterestsI am a thoracic oncologist who cares for patients with non-small cell lung cancer, malignant mesothelioma, and other thoracic malignancies. I design and conduct clinical trials of novel therapies in collaboration with other researchers and pharmaceutical companies. These generally focus on two areas, 1) targeted therapies against particular mutations in cancers (for example EGFR, ALK, ROS1, HER2, KRAS, MET, and others) and 2) the emerging field of immunotherapy in cancer, using anti PD-1/PD-L1 therapies in combination with other agents, and also developing cellular therapies. I also collaborate with other researchers on campus to apply emerging technologies to cancer therapy, for example, circulating tumor DNA detection. Additionally, in my role as the Cancer Center IT Medical Director, I coordinate projects relating to our use of the electronic health record to improve provider efficiency and facilitate patient care.
-
Robert Negrin
Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
Current Research and Scholarly InterestsOur labaratory focuses on the study of immune recognition by T and NK cells with special emphasis on graft vs host disease and graft vs tumor reactions. We utilize both murine and human systems in an effort to enhance graft vs tumor reactions while controlling graft vs host disease. We have developed bioluminescence models in collaboration with the Contag laboratory to study the trafficking of immune effector cells with a special emphasis on NK, T and regulatory T cells.
-
Joanna Nelson
Clinical Associate Professor, Medicine - Infectious Diseases
BioDr. Nelson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have had solid organ or bone marrow transplantation or who have malignancy undergoing chemotherapy. She also has a special interest in caring for patients with Cystic fibrosis or who have had a lung transplant as well as Nontuberculous mycobacterial Infections.
-
Carter Neugarten
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Neugarten is a national expert at the crossroads of palliative care and emergency medicine. He has published widely in his field, and his initiatives focus on enhancing upstream palliative care accessibility, resource optimization in healthcare, and harnessing telemedicine's potential in providing care.
His contributions include co-chairing a national committee that fosters innovation by merging these fields, and he has received grant funding to study the impact of palliative care referral from the ED.
Dr. Neugarten also has an established footprint in medical education, having held multiple formal teaching roles throughout his career. -
Andrew Nevins
Clinical Professor, Medicine - Infectious Diseases
Current Research and Scholarly InterestsClinical general infectious diseases. Medical education.
-
Linda Nguyen
Clinical Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on disorder of gastrointestinal motility. Specifically, those related to nausea and vomiting with or without gastroparesis, irritable bowel syndrome and chronic abdominal pain. My research focuses on understanding the cause of symptoms and development of new treatments targeting either symptom control and disease modification.
-
Mindie H. Nguyen, MD, MAS, AGAF, FAASLD
Professor of Medicine (Gastroenterology and Hepatology) and, by courtesy, of Epidemiology and Population Health
Current Research and Scholarly InterestsWe conduct clinical trials and epidemiological, translational, and real-world studies of liver cancer, fatty liver (NASH, NAFLD), viral hepatitis B and C, liver cirrhosis, and liver transplant. We focus on risk identification for disease prevention and treatment for improvement of survival. We focus on sex, racial/ethnic, and socioeconomic disparities. We specialize in clinical trials, large international real-world consortium registry data, and large public/semi-public databases.
-
Quan Dong Nguyen, MD, MSc
Professor of Ophthalmology and, by courtesy, of Pediatrics and of Medicine (Immunology & Rheumatology)
Current Research and Scholarly InterestsWe have focused our research on the development of novel therapies and innovative assessment and diagnostic imaging technologies for retinal vascular and ocular inflammatory disorders, specifically diabetic retinopathy (DR), age-related macular degeneration (AMD) and uveitis. Building on our initial work describing the role of hypoxia and vascular endothelial growth factor (VEGF) in diabetic retinopathy (DR) and diabetic macular edema (DME), We have become interested in the biochemical mechanisms that would presumably lead to DME. During the past decade, our research has contributed to the body of evidences that defines the important role of anti-VEGF therapies in DME and AMD, as well as the role of the mTOR pathway and various interleukins in the pathogenesis of uveitis.
We have launched a productive and well-funded clinical research program while at the same time providing clinical care to patients with uveitis and retinal vascular diseases and fulfilling significant teaching and administrative assignments. We have established a number of key collaborators both within and outside the institutions. In addition, we have also established Center in Baltimore and now in Silicon Valley, which has excelled in conducting proof-of concept, early-phase multi-center clinical trials and studies, exploring the clinical disease manifestations and the efficacy of various pharmacologic agents in retinal, uveitic, and ocular inflammatory disorders. -
Mark Nicolls
Stanford University Professor of Pulmonary and Critical Care Medicine
Current Research and Scholarly InterestsOur lab focuses primarily on the contribution of the immune response to lung disease. We are specifically examining the contribution of inflammation to the development of vascular injury in transplantation, pulmonary hypertension and lymphedema.
-
Koen Nieman
Professor of Medicine (Cardiovascular Medicine) and of Radiology (CV Imaging)
Current Research and Scholarly InterestsDr Nieman investigates advanced cardiac imaging techniques. Current projects focus on the development of functional CT application for hemodynamic interpretation of coronary artery disease, and the clinical validation of cardiac CT in the management of patients with ischemic heart disease.
-
Sankar Narayan Niranjan MD FASN
Clinical Associate Professor, Medicine - Nephrology
BioDr.Niranjan is a nephrologist (specialist in kidney diseases) with specific interests in the care of cancer patients with kidney disease (Onconephrology), high blood pressure (Hypertension) and the prevention of kidney disease.
A graduate of Kilpauk Medical College, India, he completed his medical residencies in the UK and at the University of Connecticut, where he served as Chief Medical Resident and a Nephrology Fellow. Since 2004, he served as an Attending Physician and Nephrologist at the St. Francis Hospital and Medical Center in Hartford, Connecticut, and was a partner at Greater Hartford Nephrology. He was also a Medical Director at DaVita Dialysis in Bloomfield, Connecticut until December 2023.
In addition to his clinical practice, he has mentored numerous young physicians and nephrology trainees as a community-based faculty member at the UCONN School of Medicine in Farmington, Connecticut.
His passion for the prevention and early detection of kidney disease is evident in his active involvement in the National Kidney Foundation’s Kidney Early Evaluation Program (KEEP) in Connecticut. He has facilitated screenings at inner-city community events and minority places of worship, demonstrating his commitment to reaching diverse populations. Over the last five years, he has conducted kidney disease screening camps across Southern India (most recently in June 2024), screening over 500 patients in rural areas using the KEEP template.
Dr.Niranjan is fluent in conversational Tamil, one of the oldest spoken languages in the world. He loves the outdoors and fitness - specifically hiking, bicycling and yoga. He has enjoyed traveling the world with his family. He is passionate about giving back to the community, and supports the education of underprivileged children in India through a US-based non-profit. -
Varalakshmi Niranjan, MD MBA
Clinical Associate Professor, Medicine - Primary Care and Population Health
BioDr. Varalakshmi Niranjan is a board-certified internal medicine doctor with Stanford Health Care. She is a clinical associate professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.
Dr. Niranjan practices primary care and obesity medicine using the key principles of lifestyle medicine. She focuses on the prevention and management of chronic diseases, including diabetes mellitus, hypertension, obesity, and fatty liver. She founded SMILES (Stanford Medical Intervention with Lifestyle Education Sessions) program to manage obesity. She is also the clinical lead for VBC (Value based care) project on MASLD (Metabolic Associated Steatotic Liver Disease) Dr. Niranjan has a special interest in global public health and has conducted a variety of health awareness and wellness camps in rural India.
Dr. Niranjan was the Regional Medical Director of population health for Saint Francis Healthcare Partners in Hartford, Connecticut. In her administrative role, she led many projects to improve patient safety and quality. Her research interests include ways to facilitate the teaching of lifestyle medicine, for which she received a Kaiser grant. She also received Food as Medicine Essentials Grant to implement Lifestyle Medicine education for the medical and ancillary staff at the University of Connecticut. Dr. Niranjan has also worked to develop educational tools for providers. She conducts workshops nationwide to teach primary care providers how to manage obesity with lifestyle interventions and medications. She also wrote a guidebook that offers a step-by-step approach for providers to help their patients manage obesity.
Dr. Niranjan has published her work in many peer-reviewed journals, including International Journal of Clinical Practice, Obesity Pillars, and Journal of General Internal Medicine. She is a reviewer for Obesity Pillars and Journal of Brown Hospital Medicine and has presented her work at professional meetings and conferences nationwide. In addition, she has authored several books and e-books, including a health education book and an e-cookbook of vegetarian soups for weight loss.
Dr. Niranjan is a fellow of the American College of Physicians and the Obesity Medicine Association. She is also a member of the American College of Lifestyle Medicine and Society of General Internal Medicine. -
Joyce Njoroge, MD
Clinical Assistant Professor, Medicine - Cardiovascular Medicine
BioDr. Njoroge is a board-certified physician and fellowship-trained cardiologist with the Advanced Heart Failure Program at Stanford Health Care. She is also a clinical assistant professor of medicine in the Division of Cardiovascular Medicine.
Dr. Njoroge has extensive clinical experience diagnosing and treating cardiovascular complications that develop during pregnancy or postpartum. She currently provides care at the Stanford Health Care Heart and Vascular Clinic with a particular focus on patients with a history of pregnancy-associated heart failure and cardiomyopathy.
Dr. Njoroge’s research efforts involve identifying inherited genetic changes and biological markers that could help improve screening and care for pregnant women in higher risk populations. This includes determining the causes of disproportionately high incidences of heart-related complications and deaths experienced by Black women during and after pregnancy. Dr. Njoroge is also currently recruiting patients for a large-scale, multicenter clinical trial evaluating a drug to treat cardiovascular complications during pregnancy.
Dr. Njoroge has published her work in numerous prestigious peer-reviewed journals, including Circulation Research and the Journal of Cardiac Failure. She also co-authored a chapter on cardiovascular disease in pregnancy in the most recent edition of the book Current Diagnosis and Treatment: Cardiology.
Dr. Njoroge is a member of the Association of Black Cardiologists, the American College of Cardiology, the American Heart Association, and the Heart Failure Society of America.
